Skip to content
lifestyle.fairytaleinkbooks.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Zealand Pharma
Zealand Pharma announces Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase 3 trial
April 28, 2026
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
April 22, 2026
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
April 19, 2026
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026
April 19, 2026
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
April 14, 2026
Total number of shares and voting rights in Zealand Pharma as of March 31, 2026
March 31, 2026
Zealand Pharma to participate in upcoming investor conferences in March 2026
March 9, 2026
Zealand Pharma Announces Financial Results for the Full Year 2025
February 19, 2026
Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results
February 13, 2026
←
Previous Page
1
…
3
4
5